$ALLO - Looks good this weekNASDAQ:ALLO - Looks good this week
Weekly momentum and fundamentals are good ...
Good Luck !
−2.09USD
−327.27 MUSD
95.00 KUSD
104.72 M
About Allogene Therapeutics, Inc.
Sector
Industry
CEO
David D. Chang
Website
Headquarters
South San Francisco
Founded
2017
ISIN
US0197701065
FIGI
BBG00KHRRDX3
Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. Its engineered T cells are allogeneic, which are derived from healthy donors for intended use in any patient. The company was founded by Arie S. Belldegrun, David D. Chang, David M. Tanen, and Joshua A. Kazam in November 2017 and is headquartered in South San Francisco, CA.
ALLO - short squeeze candidate This is not a financial advice!
SL under 4.4
1 TP 6.3
2 TP 8.0
3 TP 10
Only 82.54M float
49.68 short float
Most info on the chart.
Trade carefully!
Buy Opportunity in ALLOThis company is oversold in 1 Hr and $ Hrs charts. It show as bottom fishing opportunity in my Rader.
Please check other signals I released so far.
ALLOALLO Long🚀📊
PLEASE WAIT FOR ENTERING POINT
It is not financial advice. This is my opinion. Please check yourselves and invest in the symbols that you think have a huge potential to reach the best results.
please leave us your opinion and reviews.🙏
Good Luck 👍
ALLOLONG-TERM: Bullish gartley with the PCZ at an iceline, classic bullish divergence on daily/weekly. (not financial advice)
ALLO Long part 2There was a slight change in the markup. The goals remained the same. Medium-term 41-46$
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where ALLO is featured.
Frequently Asked Questions
The current price of ALLO is 3.46 USD — it has decreased by 1.42% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Allogene Therapeutics, Inc. stocks are traded under the ticker ALLO.
Allogene Therapeutics, Inc. is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
ALLO stock is 3.19% volatile and has beta coefficient of 2.75. Check out the list of the most volatile stocks — is Allogene Therapeutics, Inc. there?
One year price forecast for Allogene Therapeutics, Inc. has a max estimate of 35.00 USD and a min estimate of 4.40 USD.
ALLO earnings for the last quarter are −0.37 USD whereas the estimation was −0.52 USD which accounts for 28.78% surprise. Estimated earnings for the next quarter are −0.45 USD. See more details about Allogene Therapeutics, Inc. earnings.
Allogene Therapeutics, Inc. revenue for the last quarter amounts to 43.00 K USD despite the estimated figure of 14.46 K USD. In the next quarter revenue is expected to reach 22.00 K USD.
Yes, you can track Allogene Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
ALLO stock has fallen by 16.43% compared to the previous week, the month change is a 16.63% fall, over the last year Allogene Therapeutics, Inc. has showed a 26.85% decrease.
ALLO net income for the last quarter is −85.78 M USD, while the quarter before that showed −61.32 M USD of net income which accounts for −39.90% change. Track more Allogene Therapeutics, Inc. financial stats to get the full picture.
Today Allogene Therapeutics, Inc. has the market capitalization of 593.51 M, it has decreased by 2.21% over the last week.
No, ALLO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALLO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Allogene Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Allogene Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Allogene Therapeutics, Inc. stock shows the sell signal. See more of Allogene Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Allogene Therapeutics, Inc. future price: according to them, ALLO price has a max estimate of 35.00 USD and a min estimate of 4.40 USD. Read a more detailed Allogene Therapeutics, Inc. forecast: see what analysts think of Allogene Therapeutics, Inc. and suggest that you do with its stocks.